NCT07094204 2026-02-23A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsAstellas Pharma IncPhase 1 Recruiting364 enrolled
NCT00563316 2016-04-12Effect of Panitumumab on the Pharmacokinetics of IrinotecanAmgenPhase 1 Completed28 enrolled 11 charts
NCT00091806 2009-07-10Two Dose Schedules of Panitumumab in Subjects With Advanced Solid TumorsAmgenPhase 1 Completed86 enrolled